Loeb Offshore Management’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Loeb Offshore Management’s Portfolio AVNR Stock Details AVNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	$5.34M	Buy	+315,000	New	+$4.43M	0.98%	34

Other funds holding AVNR

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Loeb Offshore Management's AVNR Position: Q4 2014 in Review

Loeb Offshore Management opened a new position in AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q4 2014: 315,000 shares worth $5.34M. The stake represents 0.98% of the portfolio and ranks #34 among its holdings.

166 funds tracked by Wall St. Rank hold AVNR as of Q4 2014.

Loeb Offshore Management held 315,000 shares of AVANIR PHARMACEUTICALS, INC CL A worth $5.34M as of Q4 2014.
AVANIR PHARMACEUTICALS, INC CL A was a new Loeb Offshore Management position in Q4 2014.
AVANIR PHARMACEUTICALS, INC CL A made up 0.98% of Loeb Offshore Management's portfolio in Q4 2014, its #34 holding.
166 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q4 2014.

Based on Loeb Offshore Management's 13F filing for Q4 2014, filed 17 Feb 2015.